ABBV
Abbvie Inc.
Healthcare
10/13/2014
Presented
| Date | 10/06/2014 |
| Price | $56.65 |
| Market Cap | $87.60B |
| Ent Value | $95.02B |
| P/E Ratio | 54.06x |
| Book Value | $1.10 |
| Div Yield | 3.4% |
| Shares O/S | 1,593.44M |
| Ave Daily Vol | 12,140,000 |
| Short Int | 6.96% |
Current
| Price | $191.86 |
| Market Cap | $338.89B |
| AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The companys products include HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; VIEKIRA PAK, an all-oral, short-course, interferon-free therapy, with or without ribavirin, for adult patients with genotype 1 chronic hepatitis, including those with compensated cirrhosis; Kaletra, an anti-HIV-1 medicine used with other anti-HIV-1 medications as a treatment that maintains viral suppression in people with HIV-1; Norvir, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1 infection; and Synagis to prevent respiratory syncytial virus infection in high risk infants. It also provides AndroGel, a testosterone replacement therapy for males diagnosed with symptomatic low testosterone; Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid to treat hypothyroidism; and Lupron, a product for the palliative treatment of prostate cancer, and the treatment of endometriosis and central precocious puberty, as well as for the preoperative treatment of patients with anemia. In addition, the company offers Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinsons disease; Sevoflurane, an anesthesia product for human use; TriCor, Trilipix, Niaspan, Simcor, and Advicor to treat metabolic conditions characterized by high cholesterol and/or high triglycerides; and Zemplar to treat secondary hyperparathyroidism. It sells its products to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its distribution centers and public warehouses. The company has strategic collaboration with Calico Life Sciences LLC, Infinity Pharmaceuticals, Inc., Ablynx NV, Galapagos NV, Alvine Pharmaceuticals, Inc., and Action Pharma A/S. AbbVie Inc. was incorporated in 2012 and is based in North Chicago, Illinois. |
Publicly traded companies mentioned herein: AbbVie Inc (ABBV), Gilead Sciences Inc (GILD), Shire PLC (SHP LN / SHPG)
Highlights
AbbVie is in the process of acquiring Shire (SHPG), which is best known as the maker of the most prescribed ADHD medication globally, Adderall. AbbVie manufactures Humira, the leading rheumatoid arthritis medication in the world, but the opportunity is based in large part on the company’s forthcoming drug to treat hepatitis C, which should win a meaningful portion of market share from Gilead’s (GILD) blockbuster Sovaldi.
◆Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.
◆Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.